:AML使CAR T

Erden Atilla1,2, Karim Benabdellah2

  • 1Fred Hutchinson Cancer Research Center, Clinical Research Division, 1100 Fairview Ave N, Seattle, WA 98109, USA.

Cancers
|June 22, 2023
PubMed
概括

采用细胞疗法在治疗复发性/耐药性急性髓性白血病 (AML) 方面面临挑战,原因是患者异质性. 新的策略,如先进的CAR T细胞疗法和向新抗原,对于改善患者反应至关重要.